Opc Pharmaceutical JSC (STC:OPC) Cash-to-Debt: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Opc Pharmaceutical JSC Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Opc Pharmaceutical JSC's cash to debt ratio for the quarter that ended in Jun. 2026 was .

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Opc Pharmaceutical JSC couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Opc Pharmaceutical JSC's Cash-to-Debt or its related term are showing as below:

STC:OPC's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.96
* Ranked among companies with meaningful Cash-to-Debt only.

Opc Pharmaceutical JSC  (STC:OPC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Opc Pharmaceutical JSC Cash-to-Debt Related Terms


Opc Pharmaceutical JSC Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for Opc Pharmaceutical JSC's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Opc Pharmaceutical JSC Cash-to-Debt Chart

Opc Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.06 - - - -

Opc Pharmaceutical JSC Quarterly Data
Sep17 Dec17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26 Jun26
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STC:OPC vs IMNPQ, INNV: Cash-to-Debt Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Opc Pharmaceutical JSC's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opc Pharmaceutical JSC Cash-to-Debt vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Opc Pharmaceutical JSC's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Opc Pharmaceutical JSC's Cash-to-Debt falls into.



Opc Pharmaceutical JSC Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Opc Pharmaceutical JSC's Cash to Debt Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

Opc Pharmaceutical JSC had no debt (1).

Opc Pharmaceutical JSC's Cash to Debt Ratio for the quarter that ended in Jun. 2026 is calculated as:

Opc Pharmaceutical JSC had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opc Pharmaceutical JSC Business Description

Address 1017 Hong Bang Street, Ward 12, District 6, Ho Chi Minh City, VNM
Opc Pharmaceutical JSC operates as a pharmaceutical company. The company is engaged in manufacturing pharmaceutical products originating from medicinal herbs. It offers kidney stone tablets, eucalyptus oil, heart aid capsules, heart tonic, and toothache drops.